JILIN PR.HUIN.CH.BIO-P. H Aktie

Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2026, JILIN PR.HUIN.CH.BIO-P. H Aktie has already paid €0.0321 in dividends. The last payout was in July.

Financials

In the last quarter, JILIN PR.HUIN.CH.BIO-P. H Aktie had revenue of €55.33M and net profit of €15.62M

(EUR)	June 2026	YoY
Revenue	55.33M	112.93%
Gross profit	46.45M	116.92%
Net profit	15.62M	156.15%
EBITDA	17.65M	98.88%

Fundamentals

Metric	Value
Market capitalization	€167.92M
Number of shares	560.25M
52-week high/low	€0.34 - €0.21
Dividend yield	11.07%
Dividends TTM	€0.0321
Beta	0.29
P/E ratio	4.46
PEG ratio	0.09
P/B ratio	0.69
P/S ratio	1.13

Company profile

Jilin Province Huinan Changlong Bio-pharmacy Company Limited engages in the manufacture and distribution of Chinese medicines and pharmaceutical products in the People's Republic of China. It offers tablets, capsules, pills, Chinese medicine pretreatment and extraction products, powders for injections, lyophilized powder for injections, small volume injection solutions, APIs, and granules. The company markets its products under the Changlong and Qing Tong brands. The company was formerly known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited. Jilin Province Huinan Changlong Bio-pharmacy Company Limited was founded in 1989 and is based in Kowloon, Hong Kong.